 21 (11,8% vs 4, 9%; p = 0,033; OR = 2, 57
Introduction
Folates are basic resources for biosynthesis. Their metabolism requires reduction and methylation of folate to 5-methyl tetrahydrofolate. The latter is then used for the synthesis of DNA and RNA precursors or for conversion of homocysteine to methionine, the substrate for a primary DNA methylation agent, namely S-adenosylmethionine (1) . Abnormalities in the metabolism of folate and/or differences in the genes (polymorphisms) encoding enzymes involved have been described as potential risk factors for chromosomal diseases, especially trisomy 21 (2, 3) . Folate deficiency and deficiency of donors of methyl groups at the cellular level are both associated with abnormal methylation in DNA, chromosomal instability, rupture of DNA chains, aberrant chromosomal recombination, abnormal chromosome segregation, and meiotic nondisjunction of chromosomes and aneuploidies (1, 4, 5) . A hypothesis has been advanced that genitors of patients with trisomy 21 (MIM *156570) , and consequently possess altered metabolism of folate and homocysteine (2) (3) (4) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Another hypothesis states the involvement of other genes, such as methylenetetrahydrofolate dehydrogenase (5, 19) . James et al. (1999) reported that mothers of children with trisomy 21, unlike mothers of healthy children, have abnormalities in the folate metabolism, abnormalities which may be partly explained by a variation in the MTHFR gene (MIM *607093) sequence (2). Hobbs et al. (2000) noted that a combination of two polymorphisms in two genes (MTHFR gene (MIM *607093) and MTRR gene (MIM *602568)) was associated with a higher risk of trisomy 21 in children than were any of the individual polymorphisms (3). Rai et al. (2006) reported in Eastern India that the presence of two polymorphisms of the MTHFR gene (MIM *607093) (C677T and A1298C) increased the risk of trisomy 21 to a greater extent than the presence of a single polymorphism (9) . Other studies failed to demonstrate correlations between MTHFR gene (MIM *607093) polymorphisms and the risk of trisomy 21 in children (20) (21) (22) (23) (24) .
In recent years, the maternal polymorphisms of this gene have raised increasing interest, generating meta-analyses, but the results remain contradictory and the literature has yet to find a consensus. Rai et al. (2014) 
Patients and methods
A prospective study was carried out in the Medical Genetics Department of the Children's Emergency Hospital, Cluj-Napoca. The group consisted of 93 mothers of children with trisomy 21 and 202 mothers of children with normal karyotype (control group). A blood sample was collected from each subject and genotype was analysed for polymorphisms, specifically MTHFR gene (MIM *607093) C677T and A1298C.
The study was approved by the Ethics Committee of the hospital and written informed consent was obtained from participants prior to enrolment.
Genomic DNA was extracted from each 300 µL blood sample collected with EDTA using a commercial kit (Wizard Genomic DNA Purification Kit, Promega, MA, USA). DNA quality and quantity were analysed using the photometry method (Biophotometer Plus, Eppendorf, Germany).
MTHFR genotype analysis was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), using a protocol described by Zhou-Cun et al. (28, 29) . Amplification of each sample was performed using 12.5 µL PCR Mix (recombinant Taq polymerase 0.05 IU/mL, MgCl 2 4 mM, dATP, dGTP, dCTP, dTTP at a concentration of 0.4 mM each), 1 µL solution of bovine serum albumin (BSA) 2 mg/mL, 1 µL solution for each primer (1.5 pmol/µL), 2 µL DNA and nuclease-free water to a final volume of 25 µL. The amplicons obtained from the PCR were digested with the appropriate restriction enzyme (FastDigest HinfI for the C677T variant and FastDigest MboII for the variant A1298C) and identification of digestion products was performed by horizontal electrophoresis in 2.5% agarose gel.
Data were statistically analysed using Microsoft Excel and SPSS v 20.
Each gene variant was tested for HardyWeinberg equilibrium, both in the mothers of Down syndrome group and in the control group; the test was validated for p > 0.05. The frequencies of each genotype were calculated individually and the values were compared between groups using a chi-square test, considering values statistically significant for p < 0.05. The riskodds ratio (OR) was assessed when comparing the two groups. The interactions between the two genotypes (MTHFR C677T and MTHFR A1298C) were also evaluated, calculating their frequencies in each group and comparing the two groups.
The study was performed in accordance with the code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments in humans.
Results

Genotype analysis and the risk of trisomy 21
The distribution of the MTHFR C677T genotype in the group of mothers of Down syndrome (p = 0.9353) and in the control group (p = 0.7761) respected the Hardy-Weinberg equilibrium (table 1). The heterozygous genotype CT and homozygous genotype TT were found in 40.8% and 8.6% of mothers of trisomy 21 children and in 46% and 11.4%, of the control group, respectively, with no significant differences between the two groups. The combination of the two genotypes (CT/TT) was not more common among mothers of trisomy 21 children with (p > 0.05).
The distribution of the MTHFR A1298C genotype in the group of mothers of Down syndrome (p = 0.9736) and in the control group (p = 0.9736) respected the Hardy-Weinberg equilibrium (table 2). The heterozygous genotype AC and the combination of the two genotypes (AC/CC) were more common in the mothers of Down syndrome than in the control group (39.8% vs 38.6% and 51.6% vs. 43.5%), but the differences were not statistically significant (p > 0.05). The frequency of the homozygous CC genotype of the A1298C MTHFR polymorphism, however, was significantly higher in the group of mothers of Down syndrome children, OR 2.57, CI 1.053 -6.301 (p = 0.033).
Analysis of interactions between genotypes and the risk of trisomy
We evaluated the combinations of genotypes for the variant alleles MTHFR C677T and A1298C (table 3). None of the combinations proved to have any significant association with the risk for trisomy 21 in children.
Discussion
In the last decade, interest in evaluating polymorphisms of the maternal genes involved in folate metabolism in relation to the risk of trisomy 21 has increased in medical literature worldwide. Various enzymes involved in metabolic pathways of the folates were studied and different groups obtained contradictory results. The explanation could be rooted in variations of genetic structure in different populations and ethnic groups, in which different epigenetic and environmental factors are involved. (17) , which showed that the combination of the two genotypes (heterozygous AC/homozygous CC) was more frequent in mothers of trisomy 21 children than in controls. These differences were not statistically significant in the current study, however.
The homozygous genotype CC for the A1298C polymorphism of MTHFR gene (MIM *607093) was significantly more common among mothers of trisomy 21 than in the control group in our study (11.8% and 4.9%, respectively), which is similar to the findings of Meguid et al. (2008) in an Egyptian population (33.3% vs. (8) .
To date, the concern for this issue was more intense in Chinese (11, 15, 18, 26) and Indian populations (9, 14, 20, 25) . There have also been studies in Brazil (7, 12, 17) and a few studies in Arab populations, such as in the United Arab Emirates (6), Egypt (13) or Jordan (16) . Very few studies have been conducted in Caucasian populations and Europe; only in Italy (8, 10, 22) , Turkey (20, 24) , and Croatia (24) . To date, the Romanian situation has been reported in a single study investigating the polymorphisms of MTHFD gene (MIM *172460) (5) . The present study is therefore the first study to assess polymorphisms of the MTHFR gene (MIM *607093) in Romanian mothers in relation to the risk of trisomy 21 in their children.
Strengths and limitations of the study: To the best of our knowledge, this is the first Romanian study addressing the MTHFR gene polymorphisms and the risk of trisomy 21 in the offspring and also one of the few studies on European Caucasian population. The research was conducted in a single center and included a small cohort of women.
conclusion
In a Romanian population, the homozygous genotype CC of the A1298C polymorphism of the MTHFR gene (MIM *607093) is statistically significantly more frequent in mothers of trisomy 21 children than in mothers of children with normal karyotypes. This polymorphism could therefore represent a potential risk factor for trisomy 21. 
